No matching stocks found

Take a short break, or try a different search term.

Try widening your filters, clearing the search, or checking another sector.

“Good screens are built by narrowing the noise, not the signal.”

Plutux

Systems Boards Journals Stocks Insights Pricing Resources

SystemsBoardsJournalsStocksInsightsPricingResourcesMore

Eli Lilly and Company

$1,175.15

+2.46%

N/A+$28.25

Healthcare

Drug Manufacturers - General

NYSE

Active Trading

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the ...

Key Metrics Overview Fundamental Analysis Price Action Financial Highlights Financial Statements Leadership Team CEO Profile Earnings Call Transcripts Recent News Employee Count Key Products Supply Chain Insider Transactions

Key Metrics of LLY

Loading key metrics...

Loading key metrics...

About Us•Privacy Policy•Terms of Service•Join our Slack

© Plutux Technology Limited 2026

Eli Lilly and Company (LLY) valuation and key financial metrics